磁共振成像衍生的脂肪分数预测导管内乳头状黏液性肿瘤的恶性风险
本研究分析因导管内乳头状黏液性肿瘤(IPMN)行胰十二指肠切除术患者的MRI,用2点Dixon法测量胰腺脂肪分数(FFmean),比较低危组(低级别异型增生,n=29)与高危组(高级别异型增生/浸润癌,n=33)。高危组FFmean为11.45%,低危组为9.95%(p=0.027),FFmean为高危IPMN的独立预测变量(OR 1.103,p=0.035)。作者认为FFmean可能作为生物标志物辅助现有IPMN治疗决策。
要点
- 高危IPMN组胰腺FFmean为11.45%,高于低危组的9.95%(p=0.027)。
- FFmean为高危IPMN的独立预测变量(OR 1.103,p=0.035)。
- FFmean与壁结节大小、2型糖尿病、年龄、CA19-9、囊肿直径及主胰管直径相关。
核心结论
- FFmean与高危IPMN显著相关,且为IPMN恶性风险的独立预测变量;作者认为FFmean可能作为生物标志物,辅助现有IPMN治疗流程并改善关于手术切除或监测的临床决策。
研究设计与样本
- 研究论文;分析因IPMN行胰十二指肠切除术患者的MRI,低危组为低级别异型增生(n=29),高危组为高级别异型增生/浸润癌(n=33);采用2点Dixon法测量胰腺脂肪分数(FFmean),并按2017年修订版福冈共识标准评估高危征象和令人担忧的特征;同时获取血清CA19-9、糖尿病状态、BMI和组织学慢性胰腺炎资料。
关键影像表现/征象
- 高危IPMN组FFmean为11.45%,低危IPMN组为9.95%(p=0.027)。
- 血清CA19-9水平(p=0.021)、囊壁强化(p=0.029)和实性肿块(p=0.008)与高危IPMN显著相关。
- FFmean与壁结节大小(r=0.36,p<0.01)、2型糖尿病(r=0.34,p<0.01)、年龄(r=0.31,p<0.05)、血清CA19-9(r=0.30,p<0.05)、囊肿直径(r=0.30,p<0.05)及主胰管直径(r=0.26,p<0.05)显著相关。
诊断标准与关键数值
- 高危IPMN组FFmean为11.45%,低危IPMN组为9.95%(p=0.027)。
- 回归分析显示FFmean为高危IPMN的独立预测变量(OR 1.103,p=0.035)。
- 按2017年修订版福冈共识标准评估高危征象和令人担忧的特征。
临床应用与阅片要点
- 作者认为FFmean可能作为生物标志物,辅助现有IPMN治疗流程并改善关于手术切除或监测的临床决策。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Assess the relationship between MRI-derived pancreatic fat fraction and risk of malignancy in intraductal papillary mucinous neoplasm (IPMN).
METHODS: MRIs of patients with IPMN who underwent pancreaticoduodenectomy were analyzed. IPMN with low-grade dysplasia (n = 29) were categorized as low-risk while IPMN at high risk of malignancy consisted of those with high-grade dysplasia/invasive carcinoma (n = 33). Pancreatic fat-fraction (FFmean) was measured using the 2-point Dixon-method. Images were evaluated for the high-risk stigmata and worrisome features according to the revised 2017 Fukuoka consensus criteria. Data on serum CA19-9, Diabetes Mellitus (DM) status, body mass index (BMI), and histological chronic pancreatitis were obtained.
RESULTS: A significant difference in FFmean was found between the high-risk IPMN (11.45%) and low-risk IPMN (9.95%) groups (p = 0.027). Serum CA19-9 level (p = 0.021), presence of cyst wall enhancement (p = 0.029), and solid mass (p = 0.008) were significantly associated with high-risk IPMN. There was a significant correlation between FFmean and mural nodule size (r = 0.36, p ˂ 0.01), type 2 DM (r = 0.34, p ˂ 0.01), age (r = 0.31, p ˂ 0.05), serum CA 19-9 (r = 0.30, p ˂ 0.05), cyst diameter (r = 0.30, p ˂ 0.05), and main pancreatic duct diameter (r = 0.26, p ˂ 0.05). Regression analysis revealed FFmean (OR 1.103, p = 0.035) as an independent predictive variable of high-risk IPMN.
CONCLUSION: FFmean is significantly associated with high-risk IPMN and an independent predictor of IPMN malignant risk. FFmean may have clinical utility as a biomarker to complement the current IPMN treatment algorithm and improve clinical decision making regarding the need for surgical resection or surveillance.
引用
- Evrimler S, Yip-Schneider MT, Swensson J, et al. Magnetic resonance imaging-derived fat fraction predicts risk of malignancy in intraductal papillary mucinous neoplasm. Abdom Radiol (NY). 2021. PMID: 34086091. doi:10.1007/s00261-021-03146-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。